SCHEMBL16201782

SCHEMBL16201782

C=CC[C@@H](C(N)=O)[C@H](O)Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.46
MMP2 P08253 6/20 0.44
MMP3 P08254 6/20 0.44
MMP7 P09237 5/20 0.44
CYP2C19 P33261 1/20 0.42
SLC1A3 P43003 1/20 0.42
SLC1A2 P43004 1/20 0.42
SLC1A1 P43005 1/20 0.42
ALPI P09923 1/20 0.42
PKM P14618 1/20 0.42
PTGS1 P23219 1/20 0.42
XIAP P98170 1/20 0.42
SLC7A5 Q01650 1/20 0.42
MMP1 P03956 5/20 0.41
MMP8 P22894 2/20 0.41
ADAM17 P78536 1/20 0.41
MMP9 P14780 1/20 0.41
MMP12 P39900 1/20 0.41
MMP13 P45452 1/20 0.41
MMP14 P50281 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16201819 1.00 EPHX1 (0.46) EPHX1MMP2MMP3MMP7CYP2C19
SCHEMBL16201776 0.85 CYP2C19 (0.41) EPHX1MMP2MMP3MMP7CYP2C19
SCHEMBL16201773 0.85 CYP2C19 (0.41) EPHX1MMP2MMP3MMP7CYP2C19
SCHEMBL16201821 0.82 GRIK1 (0.43) MMP2MMP3MMP7CYP2C19TRPA1
SCHEMBL16201801 0.82 GRIK1 (0.43) MMP2MMP3MMP7CYP2C19TRPA1
SCHEMBL16194458 0.80 CSNK1E (0.41) EPHX1SLC1A3SLC1A2SLC1A1ALPI
SCHEMBL16194457 0.80 CSNK1E (0.41) EPHX1SLC1A3SLC1A2SLC1A1ALPI
SCHEMBL8144720 0.79 CYP1A2 (0.53) EPHX1CYP2C19SLC1A3SLC1A2SLC1A1
SCHEMBL27806639 0.75 EPHX1 (0.62) EPHX1SLC1A3SLC1A2SLC1A1ALPI
SCHEMBL8578374 0.74 EPHX1 (0.56) EPHX1SLC1A3SLC1A2SLC1A1ALPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140323457-A1 BETA-O/S/N FATTY ACID BASED COMPOUNDS AS ANTIBACTERIAL AND ANTIPROTOZOAL AGENTS Technische Universität München (DE) 2014-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140323457-A1 BETA-O/S/N FATTY ACID BASED COMPOUNDS AS ANTIBACTERIAL AND ANTIPROTOZOAL AGENTS FASN, DEGS1, EBP EPHX1 786/4885MMP2 2841/4885MMP3 1660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.